US SB1428 | 2021-2022 | 117th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 8-5)
Status: Introduced on April 28 2021 - 25% progression, died in chamber
Action: 2021-12-09 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Preserve Access to Affordable Generics and Biosimilars Act

Sponsors


History

DateChamberAction
2021-12-09SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 180.
2021-12-09SenateCommittee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
2021-07-29SenateCommittee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
2021-04-28SenateRead twice and referred to the Committee on the Judiciary.

Same As/Similar To

HB2891 (Related) 2021-09-29 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
HB5260 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB5237 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Subjects


US Congress State Sources


Bill Comments

feedback